{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:30:35Z","timestamp":1749065435108},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.transproceed.2012.10.009","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T01:51:16Z","timestamp":1366768276000},"page":"1178-1181","source":"Crossref","is-referenced-by-count":7,"title":["Recurrence of Disease After Liver Transplantation"],"prefix":"10.1016","volume":"45","author":[{"given":"S.","family":"Friman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2012.10.009_bib1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.10.009_bib2","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","article-title":"OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report","volume":"13","author":"Clavien","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.transproceed.2012.10.009_bib3","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2012.10.009_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/1471-2407-10-190","article-title":"A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma","volume":"10","author":"Schnitzbauer","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.transproceed.2012.10.009_bib5","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1432-2277.2006.00279.x","article-title":"A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma","volume":"19","author":"S\u00f6derdahl","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2012.10.009_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1432-2277.2010.01108.x","article-title":"Liver transplantation for cholangiocarcinoma","volume":"23","author":"Rosen","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2012.10.009_bib7","article-title":"Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers","author":"Murad","year":"2012","journal-title":"Met al Gastroenterol"},{"key":"10.1016\/j.transproceed.2012.10.009_bib8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3109\/00365521.2010.533384","article-title":"Liver transplantation for cholangiocarcinoma: selection is essential for acceptable results","volume":"46","author":"Friman","year":"2011","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.transproceed.2012.10.009_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/lt.21056","article-title":"Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors","volume":"13","author":"Olausson","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2012.10.009_bib10","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1432-2277.2010.01097.x","article-title":"Liver transplantation for colorectal liver metastases: revisiting the concept","volume":"23","author":"Foss","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2012.10.009_bib11","article-title":"Liver transplantation for non-resectable liver metastasis of colorectal cancer","author":"Hagness","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.transproceed.2012.10.009_bib12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jhep.2007.06.013","article-title":"Liver transplantation for anti-HCV positive patients in the Nordic countries, recurrent hepatitis and hepatocellular carcinoma severely impairs survival","volume":"47","author":"Melum","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.transproceed.2012.10.009_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/lt.21117","article-title":"A prospective evaluation of fibrosis progression in patients with recurrent hepatitis C virus following liver transplantation","volume":"13","author":"Yilmaz","year":"2007","journal-title":"Liver Transplant"},{"key":"10.1016\/j.transproceed.2012.10.009_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","author":"Rowe","year":"2008","journal-title":"Transplant Int"},{"key":"10.1016\/j.transproceed.2012.10.009_bib15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3109\/00365521.2012.672592","article-title":"Impact of donor histology on survival following liver transplantation for hepatic C virus infection","volume":"47","author":"Ydreborg","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.transproceed.2012.10.009_bib16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/lt.21396","article-title":"Steroid avoidance in liver transplantation: meta-analysis and meta-regression of randomized trials","volume":"14","author":"Segev","year":"2008","journal-title":"Liver Transplant"},{"key":"10.1016\/j.transproceed.2012.10.009_bib17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/j.1432-2277.2009.00893.x","article-title":"Corticosteroid-free immunosuppression in liver transplantation: a meta-analysis and meta-regression of outcomes","volume":"22","author":"Sgourakis","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2012.10.009_bib18","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1053\/j.gastro.2007.03.041","article-title":"Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study","volume":"132","author":"Carrion","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2012.10.009_bib19","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1600-6143.2011.03491.x","article-title":"Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation","volume":"11","author":"Coto-Llerena","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2012.10.009_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24443","article-title":"Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus","volume":"54","author":"Garg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2012.10.009_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hep.24470","article-title":"Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents-a potentially lethal cocktail","volume":"54","author":"Charlton","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2012.10.009_bib22","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJM199312163292503","article-title":"Liver transplantation in European patients with the hepatitis B surface antigen","volume":"329","author":"Samuel","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transproceed.2012.10.009_bib23","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(91)92515-4","article-title":"Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients","volume":"337","author":"Samuel","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2012.10.009_bib24","article-title":"Excellent liver transplantation survival and prevention of hepatitis B recurrence using HBIG and NUC along with treating physician adherence to treatment protocol","author":"Christine","year":"2013","journal-title":"Transpl Proc"},{"key":"10.1016\/j.transproceed.2012.10.009_bib25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clinre.2011.02.007","article-title":"Liver transplantation in PBC and PSC: indications and disease recurrence","volume":"35","author":"Carbone","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.transproceed.2012.10.009_bib26","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1002\/lt.21916","article-title":"Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis and autoimmune hepatitis after liver transplantation","volume":"15","author":"Duclos-Vallee","year":"2009","journal-title":"Liver Transplant"},{"key":"10.1016\/j.transproceed.2012.10.009_bib27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/00365520410009591","article-title":"Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism","volume":"40","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.transproceed.2012.10.009_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/lt.22004","article-title":"Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease","volume":"16","author":"Yalamanchili","year":"2010","journal-title":"Kanthi Liver Transplant"},{"key":"10.1016\/j.transproceed.2012.10.009_bib29","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2011.11.016","article-title":"Twenty-year protocol liver biopsies: invasive but useful for the management of liver recipients","volume":"56","author":"Sebagh","year":"2012","journal-title":"J Hepatol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134512011852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134512011852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T20:11:14Z","timestamp":1595707874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134512011852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0041134512011852"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2012.10.009","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}